Brighten Optix Corporation (TPEX: 6747)

Market Cap	4.11B
Revenue (ttm)	751.27M
Net Income (ttm)	189.62M
Shares Out	27.20M
EPS (ttm)	6.95
PE Ratio	21.72
Forward PE	n/a
Dividend	4.78 (3.14%)
Ex-Dividend Date	Jul 18, 2024

Volume	5,296
Open	151.00
Previous Close	152.00
Day's Range	149.50 - 151.00
52-Week Range	140.00 - 178.75
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Brighten Optix

Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers hard contact lenses under HiClear and Soclear brands; soft contact lenses under Brio+moist, iDealsoft, and MyOKvision names; contact lens care potion under the Oxy vision plus Briomoist and Mu likang brands; and other ancillary products, as well as night-wear orthokeratology hard contact lenses. Brighten Optix Corporation is based in Taipei, Taiwan.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Richard Wu
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6747

Financial Performance

In 2023, Brighten Optix's revenue was 747.30 million, an increase of 0.41% compared to the previous year's 744.27 million. Earnings were 199.24 million, a decrease of -22.02%.